Abstract
Monoamine oxidase A (MAO-A) is an important target in the pathophysiology and therapeutics of major depressive disorder, aggression, and neurodegenerative conditions. We measured the effect of changes in MAO-A substrate on MAO-A binding in regions implicated in affective and neurodegenerative disease with 11C-harmine positron emission tomography in healthy volunteers. Monoamine oxidase A V T, an index of MAO-A density, was decreased (mean: 14%±9%) following tryptophan depletion in prefrontal cortex (P<0.031), and elevated (mean: 17%±11%) in striatum following carbidopa-levodopa administration (P<0.007). These findings suggest an adaptive role for MAO-A in maintaining monoamine neurotransmitter homeostasis by rapidly compensating fluctuating monoamine levels. © 2012 ISCBFM All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Sacher, J., Rabiner, E. A., Clark, M., Rusjan, P., Soliman, A., Boskovic, R., … Meyer, J. H. (2012). Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: An in vivo 11C-harmine positron emission tomography study. Journal of Cerebral Blood Flow and Metabolism, 32(3), 443–446. https://doi.org/10.1038/jcbfm.2011.184
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.